MedPath

Comparative study of Vasaghrita drops and calcium chloride eye drop in senile cataract

Phase 1/2
Completed
Conditions
Age-related cataract,
Registration Number
CTRI/2019/03/018184
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

This study is open labelled randomized controlled clinical trial to evaluate the effect of Vasaghrit Aschyotan applied twice daily for 45 days in comparison with calcium chloride eye drops in eye/ eyes of patients affected with Kaphaj Timir. The Primary outcome will be effect of Vasaghrita Aschyotan and the secondary outcome will be the delay in maturity of senile immature cataract.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
70
Inclusion Criteria
    1. Patients suffering from symptoms of Kaphaja Timira.
    1. Patients of age group 50 to 70 yrs.
    1. Patients of either gender will be included in the study.
    1. Visual acuity of 6/12 or less.
Exclusion Criteria
  • 1)Mature and Hypermature cataract.
    1. Congenital, traumatic, complicated & metabolic cataract.
    1. Any ocular pathology that can cause diminution of vision.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A comparative clinical study to evaluate efficasy of Vasaghrita Aschyotana and Calcium Chloride eye drop in Kaphaj TimirThe drug will be given 45 days. The patients will be assessed before and after treatment. Total duratin of the study will 18 months.
Secondary Outcome Measures
NameTimeMethod
Delay in maturity of senile immature cataract.18 months

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra,Malwadi road, Hadapsar, Pune-411028

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra,Malwadi road, Hadapsar, Pune-411028
🇮🇳Pune, MAHARASHTRA, India
Vd Rajnigandha Chandraprakash Manwar
Principal investigator
9404237153
pinkymanwar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.